Tyrosine Kinase(酪氨酸激酶)
- Bcr-Abl(64)
- Ack1(2)
- Axl(6)
- ALK(54)
- BMX Kinase(3)
- Broad Spectrum Protein Kinase Inhibitor(10)
- c-FMS(35)
- c-Kit(55)
- c-MET(82)
- c-RET(7)
- CSF-1R(3)
- DDR1/DDR2 Receptor(1)
- EGFR(225)
- EphB4(1)
- FAK(33)
- FGFR(94)
- FLT3(82)
- HER2(15)
- IGF1R(33)
- Insulin Receptor(42)
- IRAK(28)
- ITK(10)
- Lck(1)
- LRRK2(21)
- PDGFR(104)
- PTKs/RTKs(3)
- Pyk2(6)
- ROR(38)
- Spleen Tyrosine Kinase (Syk)(32)
- Src(95)
- Tie-2 (4)
- Trk(40)
- VEGFR(181)
- Discoidin Domain Receptor(15)
- DYRK(28)
- Ephrin Receptor(12)
- RET(28)
- ROS(14)
- TAM Receptor(28)
- IGFBR(1)
- Others(55)
- Cat.No. 产品名称 Information
-
GC48840
9-Methoxyellipticine
Methoxy-9-ellipticine, NSC 69187
An alkaloid with anticancer activity - GC48800 SU 4942 A modulator of tyrosine kinase signaling
- GC48614 IMP-1710 A clickable UCH-L1 inhibitor
- GC48387 Inostamycin A A bacterial metabolite with anticancer activity
-
GC48332
RR-Src (trifluoroacetate salt)
Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly, RRLIEDAEYAARG, Src-Peptide
A synthetic peptide substrate - GC50706 JBJ-03-142-02 Highly potent epidermal growth factor receptor (EGFR) and ErbB2 (human epidermal growth factor receptor; HER2) inhibitor
- GC50660 HIOC HIOC 是 TrkB(原肌球蛋白相关激酶 B)受体的有效和选择性激活剂。
-
GC48118
Sunitinib-d10
舒尼替尼-D10,SU 11248-d10
An internal standard for the quantification of sunitinib - GC48070 SB-431542 (hydrate) Inhibitor of receptors ALK4, ALK5, and ALK7
-
GC48022
Radotinib-d6
IY-5511
Radotinib-d6 是氘标记的 Radotinib。 -
GC47938
Pericosine A
(+)-Pericosine A
A fungal metabolite with anticancer activity - GC47771 NG 25 (hydrochloride hydrate) An inhibitor of MAP4K2 and TAK1
-
GC47697
Mobocertinib
莫博替尼; TAK-788; AP32788
An inhibitor of mutant EGFR and HER2 receptors - GC47687 ML-209 An RORγt antagonist
- GC47570 Lipoxygenin An inhibitor of 5-LO
-
GC47452
Imatinib-d3
STI571-d3 hydrochloride; CGP-57148B-d3 hydrochloride
An internal standard for the quantification of imatinib -
GC47398
Genistein-d4
金雀异黄酮-D4,NPI 031L-d4
An internal standard for the quantification of genistein -
GC47395
Gefitinib-d6
D6-吉非替尼,ZD1839-d6
An internal standard for the quantification of gefitinib -
GC47393
Ganglioside GM1 Mixture (porcine brain) (ammonium salt)
GM1, Monosialoganglioside GM1
A sphingolipid -
GC47392
Ganglioside GM1 Mixture (ovine) (ammonium salt)
GM1, Monosialoganglioside GM1
A sphingolipid -
GC47350
Finasteride-d9
非那雄胺-D9,MK-906-d9
An internal standard for the quantification of finasteride -
GC47321
Etifoxine-13C-d3
艾替伏辛 13C-d3
A neuropeptide with diverse biological activities -
GC47303
Erlotinib-d6 (hydrochloride)
埃罗替尼-D6盐酸盐,CP-358774-d6 hydrochloride; NSC 718781-d6 hydrochloride; OSI-774-d6 hydrochloride
An internal standard for the quantification of erlotinib -
GC47182
Dehydrolithocholic Acid
3-Ketolithocholic Acid
A major metabolite of lithocholic acid -
GC46924
BIBF 1120-13C-d3
Nintedanib-13C-d3
A neuropeptide with diverse biological activities -
GC46899
Axitinib-13C-d3
阿昔替尼杂质,AG-013736 13CD3
An internal standard for the quantification of axitinib -
GC46809
Afatinib-d6
BIBW 2992 D6
An internal standard for the quantification of afatinib -
GC46628
4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline
4-氯-6,7-二(2-甲氧基乙氧基)喹唑啉
A building block and synthetic intermediate -
GC46490
1-Palmitoyl-d3-2-hydroxy-sn-glycero-3-PC
1-Hexadecanoyl-sn-glycero-3-Phosphatidylcholine-d3, 1-Hexadecanoyl-sn-glycero-3-Phosphocholine-d3, LPC-d3, 16:0/0:0(d3) Lyso-PC, 1-Palmitoyl-sn-glycero-3-Phosphocholine-d3, PC(16:0/0:0)-d3, 16:0/0:0-PC-d3
A neuropeptide with diverse biological activities -
GC46474
18-Deoxyherboxidiene
RQN-18690A
A bacterial metabolite with antiangiogenic activity - GC46304 (±)-Nebivolol-d4 (hydrochloride) A neuropeptide with diverse biological activities
- GC61217 Protein kinase inhibitors 1 hydrochloride Proteinkinaseinhibitors1hydrochloride是一种有效的HIPK2抑制剂,对HIPK1和HIPK2的IC50值分别为136和74nM,对HIPK2的Kd值为9.5nM。
-
GC61161
Osimertinib D6
AZD-9291-d6; Mereletinib-d6
OsimertinibD6(AZD-9291D6)是Osimertinib的一种氘代化合物。Osimertinib是一种不可逆和突变的选择性的EGFR抑制剂,抑制EGFRL858R和EGFRL858R/T790M的IC50分别为12和1nM。 - GC61111 NBI-31772 hydrate A nonpeptide ligand that releases IGF-1 from IGFBP
-
GC60930
Imatinib D4
[2H4]-伊马替尼,STI571 D4; CGP-57148B D4
ImatinibD4(STI571D4)是Imatinib(STI571)的氘代物。Imatinib是一种口服生物可用的酪氨酸激酶抑制剂,可选择性抑制BCR/ABL,v-Abl,PDGFR,c-kit激酶活性。 -
GC60868
Gefitinib D8
吉非替尼杂质-D8,ZD1839-d8
GefitinibD8(ZD1839D8)是Gefitinib的氘代物。Gefitinib是一种有效的(EGFR)抑制剂,在NR6wtEGFR细胞中IC50值为2-37nM。 - GC60805 EMI48 EMI48是EMI1的衍生物,EMI48比EMI1对突变型EGFR具有更大的效力。EMI48抑制EGFR三重突变体。
- GC60726 CP-547632 TFA A potent inhibitor of VEGFR2 and bFGF
-
GC60629
BDTX-189
BDTX-189
An inhibitor of wild-type and mutant EGFR and HER2 - GC60601 ARRY-382 ARRY-382 is a highly selective, oral inhibitor of the CSF1R with an IC50 of 9 nM.
- GC60592 APS6-45 APS6-45(Compound 10) is an orally active tumor-calibrated inhibitor (TCI) that inhibits RAS/MAPK signaling and exhibits antitumor activity.
- GC60567 Afatinib impurity 11 Afatinib impurity 11 is an impurity of afatinib, an EGFR family inhibitor.
- GC60372 TrkA-IN-1 TrkA-IN-1 是一种有效的选择性肌球蛋白相关激酶 A (TrkA) 抑制剂,在基于细胞的测定中,IC50 为 99 nM。TrkA-IN-1 具有镇痛作用。
- GC60365 TIE-2/VEGFR-2 kinase-IN-1 TIE-2/VEGFR-2 kinase-IN-1 用于合成 TIE-2 或者 VEGFR-2 抑制剂,从专利 WO2003022852 中获得,例 14。TIE-2/VEGFR-2 kinase-IN-1 用于研究不适当的血管生成相关疾病。
-
GC60283
Pentagamavunon-1
PGV-1
Pentagamavunon-1 (PGV-1) 是Curcumin 的类似物,具有口服活性,通过多个机制诱导凋亡信号,如抑制COX-2 和 VEGF。Pentagamavunon-1 (PGV-1) 可抑制 NF-κB 的激活。 -
GC60270
Nilotinib D6
尼罗替尼-D6,AMN107-d6
An internal standard for the quantification of nilotinib - GC60175 GIP (1-30) amide,Human acetate GIP (1-30) amide,Human acetate 是葡萄糖依赖性促胰岛素多肽 (GIP) 片段。葡萄糖依赖性促胰岛素多肽是一种肠降血糖素激素,可刺激胰岛素分泌并减少餐后血糖波动。GIP (1-30) amide (Human) 在 10-9-10-6 M 范围内剂量依赖性地促进胰岛素分泌。
-
GC60154
Erlotinib D6
CP-358774-d6; NSC 718781-d6; OSI-774-d6
An internal standard for the quantification of erlotinib -
GC39689
3-Hydroxy Midostaurin
CGP52421
3-Hydroxy Midostaurin (CGP 52421) 是 PKC412 的代谢产物,可有效抑制 FMS 样酪氨酸激酶 3 (FLT3) 自磷酸化,在培养基和血浆中的 IC50 分别为 132 nM 和 9.8 μM。与 PKC412 相比,3-Hydroxy Midostaurin 的选择性较低,但细胞毒性更高。 -
GC39623
DCC-3014
DCC-3014
Vimseltinib (DCC-3014) is a c-FMS (CSF-IR) and c-Kit dual inhibitor extracted from patent WO2014145025A2, Compound Example 10, has IC50s of <0.01 μM and 0.1-1 μM, respectively.